Combination therapy to overcome ferroptosis resistance by biomimetic self-assembly nano-prodrug

Conrad, 2019, The chemical basis of ferroptosis, Nat Chem Biol, 15, 1137, 10.1038/s41589-019-0408-1 Lei, 2022, Targeting ferroptosis as a vulnerability in cancer, Nat Rev Cancer, 22, 381, 10.1038/s41568-022-00459-0 Liang, 2019, Recent progress in ferroptosis inducers for cancer therapy, Adv Mater, 31, 10.1002/adma.201904197 Wan, 2020, Tumor-targeted cascade nanoreactor based on metal-organic frameworks for synergistic ferroptosis-starvation anticancer therapy, ACS Nano, 14, 11017, 10.1021/acsnano.9b07789 Shi, 2019, Ferroptosis in carcinoma: regulatory mechanisms and new method for cancer therapy, OncoTargets Ther, 12, 11291, 10.2147/OTT.S232852 Jiang, 2020, Transformable hybrid semiconducting polymer nanozyme for second near-infrared photothermal ferrotherapy, Nat Commun, 11, 1857, 10.1038/s41467-020-15730-x Tang, 2021, Biomedicine meets Fenton chemistry, Chem Rev, 121, 1981, 10.1021/acs.chemrev.0c00977 Yang, 2021, Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy, Asian J Pharm Sci, 16, 784, 10.1016/j.ajps.2021.05.001 Liu, 2018, Zhang, Ferrous-supply-regeneration nanoengineering for cancer-cell-specific ferroptosis in combination with imaging-guided photodynamic therapy, ACS Nano, 12, 12181, 10.1021/acsnano.8b05860 Xu, 2022, A biomimetic nanodrug self-assembled from small molecules for enhanced ferroptosis therapy, Biomater Sci, 10, 770, 10.1039/D1BM01746B Geng, 2022, Metal ion-directed functional metal–phenolic materials, Chem Rev, 122, 11432, 10.1021/acs.chemrev.1c01042 Zhou, 2022, Molybdenum-based nanomaterials for photothermal cancer therapy, Adv NanoBiomed Res, 2, 10.1002/anbr.202200065 Zhang, 2022, An ROS-activatable nanoassembly remodulates tumor cell metabolism for enhanced ferroptosis therapy, Adv Healthc Mater, 11, 10.1002/adhm.202101702 Wang, 2022, Ferroptosis-enhanced cancer immunity by a ferrocene-appended iridium (III) diphosphine complex, Angew Chem Int Ed, 134, 10.1002/ange.202115247 Chen, 2023, A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy, Acta Biomater, 159, 275, 10.1016/j.actbio.2023.01.050 Zhou, 2022, Intercalation-activated layered MoO3 nanobelts as biodegradable nanozymes for tumor-specific photo-enhanced catalytic therapy, Angew Chem Int Ed, 134, 10.1002/ange.202115939 Liu, 2022, Signaling pathways and defense mechanisms of ferroptosis, FEBS J, 289, 7038, 10.1111/febs.16059 Yang, 2014, Regulation of ferroptotic cancer cell death by GPX4, Cell, 156, 317, 10.1016/j.cell.2013.12.010 Li, 2020, Ferroptosis: past, present and future, Cell Death Dis, 11, 88, 10.1038/s41419-020-2298-2 Zhou, 2023, Facile synthesis of 2D Al-TCPP MOF nanosheets for efficient sonodynamic cancer therapy, Mater Chem Front, 7, 1684, 10.1039/D2QM01333A Ursini, 2020, Lipid peroxidation and ferroptosis: the role of GSH and GPx4, Free Radic Biol Med, 152, 175, 10.1016/j.freeradbiomed.2020.02.027 von Krusenstiern, 2023, Identification of essential sites of lipid peroxidation in ferroptosis, Nat Chem Biol, 19, 719, 10.1038/s41589-022-01249-3 Seibt, 2019, Role of GPX4 in ferroptosis and its pharmacological implication, Free Radi Biol Med, 133, 144, 10.1016/j.freeradbiomed.2018.09.014 He, 2020, Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator, Biomaterials, 241, 10.1016/j.biomaterials.2020.119911 Gutman, 2017, Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis, Lancet Infect Dis, 17, 184, 10.1016/S1473-3099(16)30378-4 Li, 2022, Cell-specific metabolic reprogramming of tumors for bioactivatable ferroptosis therapy, ACS Nano, 16, 3965, 10.1021/acsnano.1c09480 Cui, 2022, Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism, J Pharmacol Sci, 148, 73, 10.1016/j.jphs.2021.09.008 Zhang, 2021, Tailored theranostic nanoparticles cause efficient ferroptosis in head and neck squamous cell carcinoma through a reactive oxygen species “butterfly effect”, Chem Eng J, 423, 10.1016/j.cej.2021.130083 Lin, 2016, Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells, Cancer Lett, 381, 165, 10.1016/j.canlet.2016.07.033 Wan, 2019, Programmed release of dihydroartemisinin for synergistic cancer therapy using a CaCO3 mineralized metal-organic framework, Angew Chem Int Ed, 58, 14134, 10.1002/anie.201907388 Antoszczak, 2022, Iron-sensitive prodrugs that trigger active ferroptosis in drug-tolerant pancreatic cancer cells, J Am Chem Soc, 144, 11536, 10.1021/jacs.2c03973 Wang, 2014, Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines, Nano Lett, 14, 5577, 10.1021/nl502044x Karaosmanoglu, 2021, Carrier-free nanodrugs for safe and effective cancer treatment, J Control Release, 329, 805, 10.1016/j.jconrel.2020.10.014 Yang, 2022, Prodrug nanoassemblies bridged by mono-/di-/tri-sulfide bonds: exploration is for going further, Nano Today, 44, 10.1016/j.nantod.2022.101480 Li, 2021, Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery, Small, 17, 10.1002/smll.202101460 Sun, 2018, Disulfide bond-driven oxidation-and reduction-responsive prodrug nanoassemblies for cancer therapy, Nano Lett, 18, 3643, 10.1021/acs.nanolett.8b00737 Zhang, 2021, Nanoparticulation of prodrug into medicines for cancer therapy, Adv Sci, 8, 10.1002/advs.202101454 Wang, 2021, Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies, Asian J Pharm Sci, 16, 643, 10.1016/j.ajps.2021.02.001